John Nuss - Jan 2, 2025 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Signature
/s/ Austin Rutherford, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/3/2025, 06:57 PM
Previous filing
Dec 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTYX Stock Option (Right to Buy) Award $0 +245K $0.00 245K Jan 2, 2025 Common Stock 245K $2.14 Direct F1
transaction VTYX Stock Option (right to buy) Award $0 +170K $0.00 170K Jan 2, 2025 Common Stock 170K $2.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date. The Vesting Commencement Date is January 2, 2025.